United States High-Sensitivity Troponin Market Size By Type(High-Sensitivity Troponin I (hs-TnI), High-Sensitivity Troponin T(hs-TnT)), By Application(Myocardial Infarction, Acute Coronary Syndrome, Others) And Forecast

United States High-Sensitivity Troponin Market Size And Forecast

United States High-Sensitivity Troponin Market size was valued at USD 557.05 Million in 2020 and is projected to reach USD 1190 Million by 2028, growing at a CAGR of 10.04% from 2021 to 2028.

The United States High sensitivity troponin market is expected to drive the market growth due to the rising prevalence of cardiovascular diseases in the U.S. due to several factors such as smoking, obesity, diabetes, and lifestyle changes. The United States High-Sensitivity Troponin Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

What is High-Sensitivity Troponin?

High sensitivity Troponin is the preferred biomarker for the diagnosis of acute myocardial infarction. Among the cardiac biomarker tests, troponin is the biomarker test of choice for detecting heart damage. This test is performed with a blood sample using a needle to draw blood from a vein in the hand or arm. Troponin is elevated within a few hours of heart damage and stays elevated up to two weeks. The test performed for some hours helps diagnose a heart attack. High sensitivity Troponin is categorized into two types such as troponin T and troponin I. High Sensitivity Troponin T (hs-TnT) is an independent prognostic marker that helps in the diagnosis of myocardial infarction (MI) in an acute setting, and there is literature supporting its use to assess relative risk for cardiovascular disease (CVD) and adverse cardiovascular events. Whereas, the high sensitivity troponin I (hsTnI) delivers high clinical sensitivity and specificity for diagnostic accuracy, high analytical sensitivity and precision for detecting small changes at the 99th percentile, and high negative predictive value for confidence in early rule out of acute myocardial infarction (AMI).

The United States High sensitivity troponin market is expected to drive the market growth due to the rising prevalence of cardiovascular diseases in the U.S. due to the several factors such as smoking, obesity, diabetes, and lifestyle changes. According to the American Heart Association around 2,300 Americans die of cardiovascular disease each day. The high sensitivity troponin helps in monitoring the prognosis of certain condition with greater accuracy and providing the most effective treatment to the patients. Therefore, with the growing concerns regarding cardiovascular disorders, the market is expected to grow over the forecast period. However, the lack of required precision for collecting samples and limited reimbursements by government and private insurance might restrict the market growth.

United States High-Sensitivity Troponin Market Overview

The rising prevalence of cardiovascular diseases in the U.S. due to the several factors such as smoking, obesity, diabetes, and lifestyle changes. According to the American Heart Association around 2,300 Americans die of cardiovascular disease each day. The high sensitivity Troponin helps in monitoring the prognosis of certain condition with greater accuracy and providing the most effective treatment to the patients Therefore, with the growing concerns regarding cardiovascular disorders, the market is expected to grow over the forecast period. Rising research and development on cardiovascular interventions and the introduction of rapid and novel biomarker tests is expected to foster the growth of the market during the forecast period. Key market players are investing in the research and development of novel biomarkers for the diagnosis and prognosis and predictive analysis of cardiovascular disorder.

The various epidemiology studies use cardiac biomarkers to investigate different stages of diseases in humans. It requires careful handling and storage of precious biological samples with the goal of obtaining a large amount of information from limited samples and reducing the future research costs with the use of banked samples. The sample collection is thus one of the key issues faced by service providers, followed by access to these samples. Likewise, the stringent quality control is also required for these samples, and they need to be stored under the right conditions to avoid any loss. The demand for point-of-care testing (POCT) assays has increased considerably, due to the globally increasing number of cardiovascular disease patients in emergency departments (EDs) requiring urgent disease diagnosis. The adoption of point-of-care testing with cardiac biomarkers is growing in diagnostic procedures for cardiovascular diseases across the globe, owing to the advantages offered by it.

United States High-Sensitivity Troponin MarketSegmentation Analysis

The United States High-Sensitivity Troponin Market is segmented on the basis of Type And Application.

United States High-Sensitivity Troponin Market by Type

• High-Sensitivity Troponin I (hs-TnI)
• High-Sensitivity Troponin T(hs-TnT)

Based on Type, the market is bifurcated into High-Sensitivity Troponin I (hs-TnI), High-Sensitivity Troponin T(hs-TnT). High-Sensitivity Troponin I (hs-TnI) accounted for the largest market share of 73.36% in 2019, and is projected to grow at the highest CAGR of 10.27% during the forecast period. The high sensitivity troponin I (hsTnI) holds the largest market share position. It delivers high clinical sensitivity and specificity for diagnostic accuracy, high analytical sensitivity and precision for detecting small changes at the 99th percentile, and high negative predictive value for confidence in early rule out of acute myocardial infarction (AMI).

United States High-Sensitivity Troponin Market by Application

• Myocardial Infarction
• Acute Coronary Syndrome
• Others

To Get Summarized Market Report By Application-

On the basis of Application, the United States High-Sensitivity Troponin Market has been segmented into Myocardial Infarction, Acute Coronary Syndrome, Others. Acute Coronary Syndrome accounted for the largest market share of 68.27% in 2019, and is projected to grow at the highest CAGR of 10.38% during the forecast period. Acute Coronary Syndrome holds the largest market share during the forecast period. It is a condition associated with sudden, reduced blood flow to the heart. One such condition is a heart attack (myocardial infarction), when cell death results in damaged or destroyed heart tissue. Acute Coronary Syndrome (ACS) is expected to form the highest-grossing segment. This is due to the high ACS incidence poses an immense economic and social global burden.

Key Players

The “United States High-Sensitivity Troponin Market” study report will provide a valuable insight with an emphasis on the US market. The major players in the market are Roche Diagnostics (Roche Holding Ag), Abbott Laboratories, Siemens Healthineers Usa (Siemens Healthineers Ag), Beckman Coulter (Danaher Corporation).

The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players• The current as well as future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post sales analyst support

Customization of the Report

In case of any please connect with our sales team, who will ensure that your requirements are met.